arrow
M

Maya Kansara

Garvan Institute of Medical Research
H指数:17
被引数:2,903

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tucatinib and trastuzumab in advanced cancers with HER2 mutations or amplifications: a molecular screening and therapeutics (MoST) program substudy

Tucatinib和曲妥珠单抗在HER2突变或扩增的晚期癌症中的研究:分子筛查和治疗(MoST)计划子研究

2026-07-240
OA
A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutation
2024-09-091
OAAI
Tumor Biomechanics Alters Metastatic Dissemination of Triple Negative Breast Cancer via Rewiring Fatty Acid Metabolism

肿瘤生物力学通过重新连接脂肪酸代谢改变三阴性乳腺癌的转移扩散

2024-04-112
OA
Heritable defects in telomere and mitotic function selectively predispose to sarcomas
Science
IF45.8
2023-01-010
OA
Resistance to CDK2 Inhibitors Is Associated with Selection of Polyploid Cells in CCNE1-Amplified Ovarian Cancer
2013-10-31106
OAAI